Home › Leucemia linfoblastica acuta › New York
Studi clinici su Leucemia linfoblastica acuta nello stato di New York
32 studi su Leucemia linfoblastica acuta cercano partecipanti presso sedi nello stato di New York.
Città nello stato di New York
- New York City24 studi
- Queens6 studi
- The Bronx5 studi
- Rochester4 studi
- Buffalo4 studi
- Greenburgh4 studi
- New Rochelle3 studi
- Staten Island3 studi
Testo ufficiale dello studio (inglese)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età da 12 a 78 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
In reclutamentoFase 2
6 Months · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06514794Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Columbia University Medical Center, New York
In reclutamentoStudio osservazionale
4 Weeks – 18 Years · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06308588A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Montefiore Medical Center, New York
In reclutamentoFase 1/2
30 Days · Tutti i sessi · Aggiornato il 16 set 2026 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- The Mount Sinai Hospital, New York
In reclutamentoFase 1
Età da 0 a 18 · Tutti i sessi · Aggiornato il 16 set 2026 · NCT06173518Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età da 21 a 65 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT05884333First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- NYU Langone Hospital - Long Island, Mineola
- e altri 7
In reclutamentoFase 1/2
Fino a 22 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04726241A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
- Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e altri 1
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07400029A Study of CTD402 in T-ALL/LBL Patients
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
In reclutamentoFase 1/2
Età 1 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT07070219MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
- Roswell Park Cancer Institute, Buffalo
In reclutamentoVolontari sani benvenuti
Tutte le età · Tutti i sessi · Aggiornato il 12 ago 2026 · NCT06323044Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, New York
In reclutamentoFase 1/2
Età 16 e oltre · Tutti i sessi · Aggiornato il 20 lug 2026 · NCT07155226A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- e altri 9
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545A Study of Revumenib and Mezigdomide in People With Leukemia
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e altri 1
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT07356154TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1/2
Fino a 1 anni · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05848687European Prospective Investigation Into Childhood Cancer
- Columbia University Irving Medical Center, New York
In reclutamentoStudio osservazionale
Età da 3 a 21 · Tutti i sessi · Aggiornato il 2 giu 2026 · NCT05375617Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- e altri 1
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 18 mag 2026 · NCT01790152Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
In reclutamentoFase 2
Fino a 26 anni · Tutti i sessi · Aggiornato il 14 mag 2026 · NCT07566377A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1160, Stony Brook
- Ascentage Investigative Site #1151, The Bronx
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 apr 2026 · NCT06051409Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
- Roswell Park Comprehensive Cancer Center, Buffalo
In reclutamento
Età da 3 a 9 · Tutti i sessi · Aggiornato il 23 apr 2026 · NCT06074666Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
- The Mt. Hope Family Center, Rochester
In reclutamento
Età da 8 a 17 · Tutti i sessi · Aggiornato il 8 apr 2026 · NCT06956781A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Roswell Park Comprehensive Cancer Center, Buffalo
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 24 mar 2026 · NCT04988555A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
- University of Rochester Medical Center, Wilmot Cancer Center, Rochester
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 mar 2026 · NCT06207123A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
In reclutamentoFase 2
Età da 18 a 66 · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06859424Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età da 18 a 54 · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06918431A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
- Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e altri 1
In reclutamentoFase 1
Età 17 e oltre · Tutti i sessi · Aggiornato il 10 feb 2026 · NCT06287528Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 12 e oltre · Tutti i sessi · Aggiornato il 8 gen 2026 · NCT04872478A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
- Columbia University Medical Center, New York
In reclutamento
Età da 5 a 21 · Tutti i sessi · Aggiornato il 7 ott 2025 · NCT05963971Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 apr 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età da 1 a 21 · Tutti i sessi · Aggiornato il 6 dic 2024 · NCT05476770Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.